Impact Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$295K Sell
3,456
-20
-0.6% -$1.81K 0.08% 211
2026
Q2
$319K Buy
3,476
+16
+0.5% +$1.4K 0.09% 201
2026
Q1
$295K Buy
3,460
+6
+0.2% +$535 0.09% 224
2025
Q4
$273K Buy
3,454
+16
+0.5% +$1.25K 0.08% 234
2025
Q3
$275K Buy
3,438
+24
+0.7% +$2.05K 0.08% 224
2025
Q2
$310K Buy
3,414
+4
+0.1% +$365 0.1% 198
2025
Q1
$320K Buy
3,410
+33
+1% +$2.96K 0.12% 190
2024
Q4
$307K Buy
+3,377
New +$322K 0.11% 196

Other funds holding CL

Impact Capital Partners's CL Position: Q3 2026 in Review

Impact Capital Partners reduced its Colgate-Palmolive (CL) stake by 0.58% in Q3 2026, selling an estimated $1.81K and leaving 3,456 shares worth $295K. The position accounts for 0.08% of the portfolio, ranked #211.

Impact Capital Partners first reported a position in CL in Q4 2024 and has held it in 8 quarters since. The position peaked at $320K in Q1 2025. 648 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Impact Capital Partners held 3,456 shares of Colgate-Palmolive worth $295K as of Q3 2026.
  • Impact Capital Partners sold 20 Colgate-Palmolive shares in Q3 2026, an estimated $1.81K.
  • Colgate-Palmolive made up 0.08% of Impact Capital Partners's portfolio in Q3 2026, its #211 holding.
  • Impact Capital Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 8 quarters since.
  • Impact Capital Partners's Colgate-Palmolive position peaked at $320K in Q1 2025.
  • 648 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Impact Capital Partners's 13F filing for Q3 2026, filed 22 Oct 2026.